Literaturverzeichnis 2019


Hier finden Sie die Literaturangaben zu den Übersichtsartikeln der Zeitschrift für Infektionstherapie aus dem Jahr 2019




Heft 3, 2019

Heft 2, 2019

Heft 1, 2019



Literaturangaben zum Übersichtsartikel aus

Heft 3 / 2019 der Zeitschrift für Infektionstherapie


Neue Antibiotika - geht die Entwicklung am Bedarf vorbei?


1: Theuretzbacher U et al. Analysis of the clinical antibacterial and antituberculosis pipeline. Lancet Infect Dis. 2019 Feb;19(2):e40-e50 PubMed


2: Jean SS, Gould IM, Lee WS, Hsueh PR; International Society of Antimicrobial Chemotherapy (ISAC). New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship. Drugs. 2019 May;79(7):705-714 PubMed


3: Cox E, Nambiar S, Baden L. Needed: Antimicrobial Development. N Engl J Med. 2019 Feb 21;380(8):783-785  PubMed


4: Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR,  Connolly LE, Miller LG, Friedland I, Dwyer JP; EPIC Study Group. Once-Daily Plazomicin for Complicated Urinary Tract Infections. N Engl J Med. 2019 Feb 21;380(8):729-740 PubMed


5: McKinnell JA, Dwyer JP, Talbot GH, Connolly LE, Friedland I, Smith A, Jubb AM, Serio AW, Krause KM, Daikos GL; CARE Study Group. Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae. N Engl J Med. 2019 Feb 21;380(8):791-793 PubMed


6: Guidance for industry: antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases. Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research, 2013



Literaturangaben zum Übersichtsartikel aus

Heft 2 / 2019 der Zeitschrift für Infektionstherapie


Langzeittherapie mit Antibiotika: Gibt es sinnvolle Indikationen?


1: Lau JSY, Korman TM, Woolley I. Life-long antimicrobial therapy: where is the evidence? J Antimicrob Chemother. 2018 Oct 1;73(10):2601-2612


2: Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR; Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013 Jan;56(1):e1-e25


3: Parvizi J, Gehrke T, Chen AF. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J. 2013 Nov;95-B(11):1450-2


4: Leroy O, Meybeck A, Sarraz-Bournet B, d'Elia P, Legout L. Vascular graft infections. Curr Opin Infect Dis. 2012 Apr;25(2):154-8 Review


5: Wilson WR et al. Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association. Circulation. 2016 Nov 15;134(20):e412-e460


6: Sandoe JA et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. J Antimicrob Chemother 2015 Feb;70(2):325-59


7: Tan EM, DeSimone DC, Sohail MR, Baddour LM, Wilson WR, Steckelberg JM, Virk A.Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression. Clin Infect Dis. 2017 Jun 1;64(11):1516-1521


8: Jones P, Leder K, Woolley I, Cameron P, Cheng A, Spelman D. Postsplenectomy infection - strategies for prevention in general practice. Aust Fam Physician. 2010 Jun;39(6):383-6


9: Davies JM, Lewis MP, Wimperis J, Rafi I, Ladhani S, Bolton-Maggs PH; British Committee for Standards in Haematology. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force. Br J Haematol. 2011 Nov;155(3):308-17 Review



10: Grimwade K, Swingler, G. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV. Cochrane Database Syst Rev. 2003;(3):CD003108 Review


11: Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005590 Review


12: Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev. 2004 Oct;17(4):770-82 Review


13: Dason S, Dason JT, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011 Oct;5(5):316-22


14: Williams G, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001534


15: WHO Expert consultation Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation, Geneva, 20 October - 1 November 2001. Geneva : World Health Organization


16: Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, Taubert KA. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement

Circulation. 2009 Mar 24;119(11):1541-51.


17: European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010 Sep;53(3):397-417 Review


18: Runyon BA; AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009 Jun;49(6):2087-107


19: Cohen MJ, Sahar T, Benenson S, Elinav E, Brezis M, Soares-Weiser K. Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004791 Review


20: Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B; Pulmonary Clinical Practice Guidelines Committee. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013 Apr 1;187(7):680-9 Review


21: Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur J Clin Pharmacol. 2012 May;68(5):479-503 Review


22: Wang Y, Zijp TR, Bahar MA, Kocks JWH, Wilffert B, Hak E. Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2018 Dec 1;73(12):3231-3243


23: Garner SE, Eady EA, Popescu C, Newton J, Li WA. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev. 2003;(1):CD002086 Review


24: Khan KJ, Ullman TA, Ford AC, Abreu MT, Abadir A, Marshall JK, Talley NJ, Moayyedi P. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011;106(4):661-73 Review.


25: Wang SL, Wang ZR, Yang CQ. Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Exp Ther Med. 2012 Dec;4(6):1051-1056


26: Nitzan O, Elias M, Peretz A, Saliba W. Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol. 2016 Jan 21;22(3):1078-87 Review





Literaturangaben zum Übersichtsartikel aus

Heft 1 / 2019 der Zeitschrift für Infektionstherapie


Therapie der chronischen Hepatitis B


1. von Laer A, Harder T, Zimmermann R, Dudareva S: Virushepatitis B und D im Jahr 2017. Epid Bull 2018;30:285 – 294 (PDF-Datei)


2. Ständige Impfkommission: Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epid Bull 2018;34:335 – 382 (PDF-Datei)


3. Seto WK, Lo YR, Pawlotsky JM, Yuen MF. Chronic hepatitis B virus infection. Lancet. 2018 Nov 24;392(10161):2313-2324


4. European Association for the Study of the Liver. Electronic address:; European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370-398


5. Lai CL et al. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B. J Hepatol. 2017 Feb;66(2):275-281


6. Brown RS Jr, McMahon BJ, Lok AS, Wong JB, Ahmed AT, Mouchli MA, Wang Z, Prokop LJ, Murad MH, Mohammed K. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatology. 2016 Jan;63(1):319-33 FREE FULL TEXT


7. Gois PH et al. Tenofovir during pregnancy in rats: a novel pathway for programmed hypertension in the offspring. J Antimicrob Chemother. 2015 Apr;70(4):1094-105


Informationen für Ärzte und Apotheker zur rationalen Infektionstherapie

Die Zeitschrift für Infektionstherapie (bis 2015: "Zeitschrift für Chemo-therapie") erscheint im Jahr 2019 im 40. Jahrgang. Herausgeber und Redaktion sind bemüht, Sie kontinu-ierlich und aktuell über wichtige Entwicklungen im Bereich der Infektionstherapie zu informieren.


Die vollständigen, aktuellen Ausgaben der Zeitschrift sind nur im Abonnement erhältlich.


Nach 24 Monaten stehen die Hefte als PDF-Dateien  frei zur Verfügung (Frühere Ausgaben und Register).


Wir bieten Ihnen auf diesem Wege ebenfalls alle Artikel der Rubrik "Neueinführungen" und einige andere regelmäßige Beiträge aus der Zeitschrift an.


Letzte Aktualisierung dieser Seiten:

5. Juni 2019

Druckversion Druckversion | Sitemap
© Zeitschrift für Infektionstherapie